Mobility Global Inc. Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? Mobility Global Inc. Common Stock trades at $17.85 (market cap $5.80B), while Relay Therapeutics Inc. Common Stock trades at $17.07 (market cap $3.81B). The key difference: Mobility Global Inc. Common Stock is the larger of the two by market cap, and Mobility Global Inc. Common Stock pays a 1.33% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Mobility Global Inc. Common Stock for 0 Days and Relay Therapeutics Inc. Common Stock for 5 Days on average.
| MBGL | RLAY | |
|---|---|---|
Market Cap | $5.80B | $3.81B |
Volume | 2,595,123 | 1,706,150 |
Sector | Technology | Health |
52-Week High | $22.26 | $20.75 |
52-Week Low | $17.15 | $6.05 |
Typical Hold Time | 0 Days | 5 Days |
Enterprise Value | $7.62B | $2.93B |
Dividend Yield | 1.33% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Relay Therapeutics (RLAY) trades at $17.36, down 3.45% today, with technical indicators showing bearish momentum. The company remains in clinical-stage development with negative profitability metrics, including a -2,763.64% net income margin and -$276.48M net loss for 2025. Recent Q2 2026 earnings missed expectations with a loss of $0.41 per share, though the company continues advancing its oncology pipeline with Phase 3 trials planned for 2027.
Despite unanimous analyst buy ratings and a $26.25 consensus price target representing 51% upside, RLAY faces significant execution risk as a pre-revenue biotech. The stock's bearish technical setup and persistent cash burn require careful risk management, though institutional accumulation and AI-driven drug discovery platform provide long-term potential.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Mobility Global Inc. provides automotive data and analytics across the vehicle lifecycle, operating brands including CARFAX, automotiveMastermind, Polk Automotive Solutions, and Market Scan for automakers, dealers, and consumers.
Read more on MBGL →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →